Prenetics Global Ltd Class A PRE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.97
- Day Range
- $4.56–4.92
- 52-Week Range
- $2.85–15.90
- Bid/Ask
- $4.46 / $4.97
- Market Cap
- $56.27 Mil
- Volume/Avg
- 69,035 / 139,782
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.66
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 400
- Website
- https://www.prenetics.com
Comparables
Valuation
|
Metric
|
PRE
|
06667
|
06606
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 111.65 | 102.36 |
Price/Book Value | 0.25 | 3.04 | 2.01 |
Price/Sales | 0.66 | 11.51 | 4.21 |
Price/Cash Flow | — | 101.82 | — |
Price/Earnings
PRE
06667
06606
Financial Strength
|
Metric
|
PRE
|
06667
|
06606
|
|---|---|---|---|
Quick Ratio | 1.92 | 8.99 | 10.14 |
Current Ratio | 2.61 | 9.03 | 10.77 |
Interest Coverage | — | — | −1.14 |
Quick Ratio
PRE
06667
06606
Profitability
|
Metric
|
PRE
|
06667
|
06606
|
|---|---|---|---|
Return on Assets (Normalized) | −4.26% | 0.23% | 2.20% |
Return on Equity (Normalized) | −5.48% | 0.26% | 2.63% |
Return on Invested Capital (Normalized) | −6.85% | 0.22% | 2.17% |
Return on Assets
PRE
06667
06606
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Wgffqsxvx | Txdv | $209.3 Bil | |
DHR
| Danaher Corp | Mxvqbphcp | Lptswxt | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Dknrxmxtb | Hlyyyn | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Bggfhxqbtc | Bvhjgcq | $41.5 Bil | |
A
| Agilent Technologies Inc | Lqcwlxgmh | Fqyt | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Hdjjybbwy | Bqbbgb | $26.5 Bil | |
ICLR
| Icon PLC | Stnkgjhwb | Wctmg | $24.8 Bil | |
ILMN
| Illumina Inc | Cgwplwphb | Yhqtts | $19.5 Bil | |
WAT
| Waters Corp | Bfwqdgcl | Xwg | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Cwywxjwgp | Zcdkjp | $16.7 Bil |